Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021312
Filing Date
2020-02-14
Accepted
2020-02-14 13:14:38
Documents
1
Group Members
GILEAD SCIENCES IRELAND UC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a20-7949_1sc13ga.htm SC 13G/A 70542
  Complete submission text file 0001104659-20-021312.txt   72142
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90985 | Film No.: 20617286
SIC: 2834 Pharmaceutical Preparations